On Wednesday, the European Union said that it would get 50 million Pfizer vaccine doses earlier than expected after Denmark banned use of AstraZeneca over blood clot links.
The news broke out after U.S. drugmaker Johnson & Johnson delayed its Covid-19 shot among rising caseloads. Referring to the delay, EU Commission chief Ursula von der Leyen said “there are still many factors that can disrupt the planned delivery schedules of vaccines.”
The EMA said J&J was in contact with national authorities and recommended storing doses already received until the safety committee issued an expedited recommendation, reports Reuters.
Europe will receive BioNTech/Pfizer vaccine doses in the second quarter of this year and the delivery will start as soon as this month.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…